Your search for major depressive disorder returned 161 results

Researchers conducted a phase 2 trial to assess the safety and efficacy of single-dose psilocybin treatment for major depressive disorder.

An umbrella review assessed the safety and efficacy of antidepressants in patients with depression and comorbid medical diseases.

Researchers analyzed MRI-derived images of participants with mental illness to evaluate the heterogeneity of gray matter volume deviations.

Researchers investigated the all-cause risk for mortality in patients with major depressive disorder exhibiting suicidal behavior.

In a systematic review and meta-analysis, estimates for depressive disorders in children younger than 13 years old were evaluated.

Review authors aimed to assess the effect of educational interventions on knowledge acquisition and health outcomes in adolescents with feeding and eating disorders.

Researchers evaluated the magnitude, timing, and durability of antidepressant effects and safety of a single dose of psilocybin in patients with major depressive disorder.

Researchers examined the patient burden of tardive dyskinesia.

Researchers sought to assess the cognitive effects of PTSD in patients with drug-resistant epilepsy who have PTSD symptoms.

A study sought to determine the prevalence of depression and cognitive dysfunction in patients receiving TAVR for aortic stenosis and its effect on mortality.

Researchers evaluated the risk for major depressive disorder among patients with HIV infection.

Botulinum toxin injections can improve quality of life for patients across a variety of aspects of health care, including pain management, urology, dermatology, and more.

A study was conducted to determine the effect of mental health disorders on postoperative outcomes following EVAR in patients who are veterans.

In a retrospective cohort study, researchers assessed the association between prurigo nodularis with sleep disorders.

Ulotaront is a trace amine-associated receptor 1 agonist with 5-HT1A agonist activity.

Researchers sought to assess the association between sleep-related adverse events and antidepressant dosage.

Researchers sought to assess how objective cognitive deficits in depression are associated with symptoms, neural circuits, and treatment outcomes.

Researchers searched for protective effects in gut microbiota from the pathogenesis of major depressive disorder.

Researchers assessed characteristics and correlates of metabolic syndrome in adolescents with major depressive disorder or bipolar disorder depression.

Researchers evaluated the efficacy of dextromorphan-bupropion among patients with major depressive disorder and comorbid anxiety.

However, expansion of telehealth yielded net increase in care for major depressive disorder, anxiety, and adjustment disorder

Adults with major depressive disorder and a history of childhood trauma can still benefit from recommended depression treatments.

Whether major depressive disorder is a comorbidity of bipolar disorder isn’t really known. Researchers built a predictive model of major depressive disorder to bipolar disorder conversion and with the Observational Medical Outcomes Partnership validated the results across a multi-national network of patient databases.

Investigators report the findings from a study assessing the impact of insomnia on clinical outcomes in patients with major depressive disorder.

The researchers sought to examine whether inflammation and white matter microstructure play a role in treatment response in major depressive disorder.

Authors say findings similar across people with schizophrenia, major depressive disorder, and bipolar disorder in three distinct geographic settings

In a multicenter, observational, cohort study, researchers investigated the incidence dynamics and long-term neurologic outcome of neuro-COVID disorders.

An additional 53.2 million cases of major depressive disorder and 76.2 million cases of anxiety disorders globally were estimated due to the COVID-19 pandemic.

Researchers seek to evaluate whether trauma-focused therapy adjunctive to treatment as usual (TAU) leads to a greater reduction of depressive symptoms posttreatment vs TAU exclusively in patients with major depressive disorder with childhood trauma.

Researchers compared the white matter networks of patients with remitted major depressive disorder and remitted bipolar disorder to find disease-specific alterations.